Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.

DMedical announced today that it raised more than $100 million (AU$150 million) through a new institutional placement.

BD (NYSE: BDX) today set the record date for the planned spin-off of its Biosciences & Diagnostics business to Waters ...

Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.

Robocath announced today that it launched a first-in-human clinical study evaluating its new robotic system in coronary artery disease.

Outset Medical (Nasdaq: OM) announced today that it received FDA 510(k) clearance for its next-generation Tablo hemodialysis platform.

Masimo (Nasdaq:MASI) has opposed an attempt by Apple to overturn the recent patent infringement ruling ordering it to pay $634 million.

Oath Surgical announced today that it entered into a collaboration with Nvidia to support its OathOS platform.